RESPIRATION
Scope & Guideline
Championing Excellence in Pulmonary Science
Introduction
Aims and Scopes
- Clinical Management of Respiratory Diseases:
This area encompasses studies on the diagnosis, treatment, and management strategies for various respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung disease. - Innovative Therapeutic Approaches:
Research in this scope includes the development and evaluation of new therapies, such as biologics, endobronchial valves, and minimally invasive procedures like cryobiopsy and robotic-assisted bronchoscopy. - Pulmonary Rehabilitation and Patient Quality of Life:
This focus area examines the impact of rehabilitation programs and interventions on improving quality of life and functional outcomes for patients with chronic respiratory illnesses. - Epidemiological and Public Health Studies:
Studies aimed at understanding the prevalence, risk factors, and public health implications of respiratory diseases, including those related to COVID-19, tuberculosis, and environmental influences. - Technological Advances in Diagnostics:
This includes research on the use of advanced imaging techniques, such as CT and ultrasound, and novel diagnostic tools for accurate assessment of pulmonary conditions. - Translational Research in Pulmonology:
This scope emphasizes the integration of laboratory findings into clinical practice, including studies on biomarkers, genetic factors, and the molecular mechanisms underlying respiratory diseases.
Trending and Emerging
- Impact of COVID-19 on Respiratory Health:
A significant increase in research focused on the long-term effects of COVID-19, including pulmonary sequelae and rehabilitation strategies for recovering patients, highlighting the pandemic's lasting impact on respiratory health. - Personalized Medicine and Targeted Therapies:
An emerging focus on personalized approaches in treatment, including the use of biomarkers for predicting responses to therapies, particularly in chronic conditions like asthma and COPD. - Telemedicine and Remote Monitoring:
The rise of telemedicine in the management of respiratory diseases, driven by the COVID-19 pandemic, is becoming a prominent theme, emphasizing the need for innovative solutions for patient care. - Integration of Multidisciplinary Approaches:
Research increasingly emphasizes collaborative approaches involving pulmonologists, radiologists, and other specialists to enhance diagnostic accuracy and treatment outcomes in complex respiratory conditions. - Environmental and Lifestyle Factors in Respiratory Diseases:
Growing interest in the impact of environmental factors, such as air quality and lifestyle habits, on respiratory health, reflecting a broader understanding of disease etiology.
Declining or Waning
- Traditional Surgical Approaches in Pulmonary Medicine:
There is a noticeable decrease in studies focusing on conventional surgical interventions for lung diseases, as more attention shifts towards minimally invasive techniques and non-surgical treatment options. - Longitudinal Cohort Studies without Novel Insights:
Research involving long-term follow-ups without significant novel findings or advancements in understanding disease mechanisms appears to be less prioritized, as the field moves towards more innovative and impactful studies. - Basic Research in Animal Models:
There has been a reduction in papers focusing solely on animal model studies without direct translational relevance to human respiratory diseases, reflecting a growing preference for research that can be quickly applied in clinical settings.
Similar Journals
THORAX
Elevating respiratory research to new heights.THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.
Lung India
Catalyzing change in pulmonary practices worldwide.Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.
Indian Journal of Respiratory Care
Elevating Standards in Pulmonary MedicineWelcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.
Canadian Journal of Respiratory Critical Care and Sleep Medicine
Transforming critical care through rigorous research.Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.
Chronic Respiratory Disease
Fostering collaboration in respiratory health advancements.Chronic Respiratory Disease is a leading peer-reviewed journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by SAGE Publications Ltd since its inception in 2004, this open-access journal has been at the forefront of disseminating high-quality research aimed at addressing chronic respiratory conditions. With an impressive impact factor and classified as Q1 in the 2023 category of Pulmonary and Respiratory Medicine, it ranks an admirable #45 out of 155 in Scopus, placing it in the 71st percentile of its field. This journal features a diverse range of studies, reviews, and clinical insights that cater to researchers, healthcare professionals, and students alike, encouraging the exchange of innovative ideas and practices in respiratory disease management. Operating out of London, UK, Chronic Respiratory Disease exemplifies a commitment to openness, having transitioned to open access since 2017, thereby ensuring that pivotal research is readily accessible to a global audience engaged in the improvement of respiratory health.
Journal of Thoracic Disease
Advancing respiratory health through innovative research.Welcome to the Journal of Thoracic Disease, a premier scholarly journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by AME PUBLISHING COMPANY in Hong Kong, this journal has established itself as a critical platform for the dissemination of innovative research and clinical advancements since its inception in 2009. With an impressive Q2 ranking in the Scopus category of Pulmonary and Respiratory Medicine, it is recognized for its contribution to the academic community, featuring a broad range of original research, reviews, and case studies that address contemporary challenges in thoracic disease management. The journal is committed to Open Access principles, ensuring that high-quality research is readily available to a global audience, further enhancing its impact factor and reach. Researchers, healthcare professionals, and students alike will find invaluable insights within its pages, making Journal of Thoracic Disease an essential resource for those invested in the respiratory health domain.
RESPIRATORY MEDICINE
Championing Excellence in Pulmonary ResearchRespiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.
RESPIROLOGY
Championing Collaborative Research in RespirologyRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
Thoracic Research and Practice
Pioneering Discoveries in Pulmonary and Respiratory MedicineThoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.
Zeitschrift fur Pneumologie
Advancing Lung Health Through Innovative ResearchZeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.